Silicone oil, commonly used as an endo-tamponade in vitreoretinal surgeries, can lead to secondary glaucoma, often due to emulsified silicone oil obstructing the drainage of aqueous humor. In cases where silicone oil triggers acute pupillary block, it hinders the normal flow of aqueous humor into the anterior chamber, ultimately displacing it and completely filling the chamber. Patients experiencing this phenomenon typically present with sudden ocular pain and increased intraocular pressure; however, its diagnosis can be challenging due to the absence of classic pupillary block indicators like a shallow anterior chamber or iris bombe. Through a case study, Dr. Sahiti Puttagunta and colleagues elucidate this infrequent and elusive clinical scenario. Watch: aao.org/education/clinical-v… #AAO

.@RepWilson (D-FL) introduced in the U.S. House of Representatives the Glaucoma Vision Act of 2026. This legislation would require coverage of annual glaucoma screenings for people at increased risk of glaucoma. It applies to four major health coverage programs (private Insurance, Medicare Part B, Medicaid, and Federal Employees Health Benefits) and eliminates applicable cost sharing for such screenings. It also includes a competitive grant program to provide free or low-cost glaucoma screenings and follow-up care for uninsured and underinsured individuals. It authorizes $10 million in competitive @NatEyeInstitute research grants to find better ways to detect and manage glaucoma. The Academy appreciates Rep. Wilson’s leadership in introducing this important legislation. Joining us in our support of this legislation are the @AGSDocs, @ASCRStweets, @ARVOinfo, @NAEVRAdvocacy, @CorneaSociety, and the Macula Society. #GlaucomaVisionAct #AAO